Needle with a novel attachment versus conventional screw-thread needles: A preference and ease-of-use test among children and adolescents with diabetes

Journal of Diabetes Science and Technology

Volumn 5, Issue 6, 2011, Pages 1480-1487

  Hofman, Paul ^a   Lilleøre, Søren Kruse ^b   Ter Borch, Gitte ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Attachment; Diabetes; Ease of use; Insulin pens; NovoTwist

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; INSTRUMENTATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEEDLE; PATIENT PREFERENCE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; CHILD; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; NEEDLES; PATIENT PREFERENCE; SELF ADMINISTRATION;

EID: 84862646262     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500623     Document Type: Article

References (26)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
2. Hood KK, Peterson CM, Rohan JM, Drotar D. Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics. 2009;124(6):e1171-9.
3. Baser O, Bouchard J, DeLuzio T, Henk H, Aagren M. Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe. Adv Ther. 2010;27(2):94-104.
4. Cobden D, Lee WC, Balu S, Joshi AV, Pashos CL. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus. Pharmacotherapy. 2007;27(7):948-62. (Pubitemid 46986681)
5. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther. 2006;28(10):1712-25. (Pubitemid 44841979)
6. Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Clin Ther. 2007;29 Spec No:1294-305. (Pubitemid 351172225)
7. Olsen BS, Lilleøre SK, Korsholm CN, Kracht T. Novopen Echo® for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents, and health care professionals. J Diabetes Sci Technol. 2010;4(6):1468-75.
8. Hanas R, Ludvigsson J. Experience of pain from insulin injections and needle phobia in young patients with IDDM. Pract Diabetes Int. 1997;14(4):95-9. (Pubitemid 27359267)
9. Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther. 2005;27 Suppl B:S89-100.
10. Perfetti R. Reusable and disposable insulin pens for the treatment of diabetes: understanding the global differences in user preference and an evaluation of inpatient insulin pen use. Diabetes Technol Ther. 2010;12 Suppl 1:S79-85.
11. Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care. 1999;22(1):137-40. (Pubitemid 29028310)
12. Hansen B, Lilleøre SK, Ter-Borch G. Needle with a novel attachment versus conventional screw-thread needles: a preference and usability test among adults with diabetes and impaired manual dexterity. Diabetes Technol Ther. 2011;13(5):579-85.
13. Sommavilla B, Jørgensen C, Jensen KH. Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opin Pharmacother. 2008;9(13):2223-32.
14. Lytzen L, Ostfeldt L. Comparative assessment of NovoTwist™, a novel insulin pen needle system. 1985-PO. American Diabetes Association 69th Scientific Sessions, 2009.
15. Cameron FJ, Skinner TC, de Beaufort CE, Hoey H, Swift PG, Aanstoot H, Aman J, Martul P, Chiarelli F, Daneman D, Danne T, Dorchy H, Kaprio EA, Kaufman F, Kocova M, Mortensen HB, Njølstad PR, Phillip M, Robertson KJ, Schoenle EJ, Urakami T, Vanelli M, Ackermann RW, Skovlund SE; Hvidoere Study Group on Childhood Diabetes. Are family factors universally related to metabolic outcomes in adolescents with Type 1 diabetes? Diabet Med. 2008;25(4):463-8. (Pubitemid 351490117)
16. Mulvaney SA, Mudasiru E, Schlundt DG, Baughman CL, Fleming M, VanderWoude A, Russell WE, Elasy TA, Rothman R. Self-management in type 2 diabetes: the adolescent perspective. Diabetes Educ. 2008;34(4):674-82.
17. Anderson BJ, Brackett J, Ho J, Laffel LM. An office-based inter-vention to maintain parent-adolescent teamwork in diabetes management. Impact on parent involvement, family conflict, and subsequent glycemic control. Diabetes Care. 1999;22(5):713-21. (Pubitemid 29220769)
18. Anderson BJ, Vangsness L, Connell A, Butler D, Goebel-Fabbri A, Laffel LM. Family conflict, adherence, and glycaemic control in youth with short duration type 1 diabetes. Diabet Med. 2002;19(8):635-42. (Pubitemid 34985163)
19. Berg CA, Butler JM, Osborn P, King G, Palmer DL, Butner J, Murray M, Lindsay R, Donaldson D, Foster C, Swinyard M, Wiebe DJ. Role of parental monitoring in understanding the benefits of parental acceptance on adolescent adherence and metabolic control of type 1 diabetes. Diabetes Care. 2008;31(4):678-83.
20. Duke DC, Geffken GR, Lewin AB, Williams LB, Storch EA, Silverstein JH. Glycemic control in youth with type 1 diabetes: family predictors and mediators. J Pediatr Psychol. 2008;33(7):719-27. (Pubitemid 351957527)
21. Helgeson VS, Reynolds KA, Siminerio L, Escobar O, Becker D. Parent and adolescent distribution of responsibility for diabetes self-care: links to health outcomes. J Pediatr Psychol. 2008;33(5):497-508.
22. Leonard BJ, Garwick A, Adwan JZ. Adolescents' perceptions of parental roles and involvement in diabetes management. J Pediatr Nurs. 2005;20(6):405-14. (Pubitemid 41628084)
23. Miller-Johnson S, Emery RE, Marvin RS, Clarke W, Lovinger R, Martin M. Parent-child relationships and the management of insulin-dependent diabetes mellitus. J Consult Clin Psychol. 1994;62(3):603-10. (Pubitemid 24198434)
24. Arendt-Nielsen L, Egekvist H, Bjerring P. Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res. 2006;23(1-2):37-43. (Pubitemid 44114991)
25. Hofman PL, Derraik JG, Pinto TE, Tregurtha S, Faherty A, Peart JM, Drury PL, Robinson E, Tehranchi R, Donsmark M, Cutfield WS. Defining the ideal injection techniques when using 5-mm needles in children and adults. Diabetes Care. 2010;33(9):1940-4.
26. Tubiana-Rufi N, Belarbi N, Du Pasquier-Fediaevsky L, Polak M, Kakou B, Leridon L, Hassan M, Czernichow P. Short needles (8 mm) reduce the risk of intramuscular injections in children with ty1pe 1 diabetes. Diabetes Care. 1999;22(10):1621-5. (Pubitemid 29458383)